Q2 2026 revenue reached $29.8 million, led by e-commerce and international growth, with stable gross margins and a strong cash position. Expansion into skincare, IV/injection, and pharmaceuticals is underway, with major product launches and partnerships expected to drive growth in 2027.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.